已收盘 02-06 16:00:00 美东时间
+30.390
+6.36%
今日重点评级关注:Oppenheimer:维持Pelthos Therapeutics"跑赢大市"评级,目标价从57美元升至60美元;Small Cap Consumer Research:维持Lands' End"买入"评级,目标价从20美元升至45美元
01-27 10:02
Stifel analyst Brian Brophy maintains Quanta Services (NYSE:PWR) with a Buy and raises the price target from $495 to $517.
01-26 21:14
Quanta Services (NYSE:PWR) has outperformed the market over the past 10 years b...
2025-12-30 06:36
今日重点评级关注:HC Wainwright & Co.:维持Pyxis Oncology"买入"评级,目标价从5美元升至7美元;Stifel:维持Oculis Holding"买入"评级,目标价从35美元升至40美元
2025-12-22 15:05
Bernstein analyst Chad Dillard maintains Quanta Services (NYSE:PWR) with a Market Perform and lowers the price target from $432 to $428.
2025-12-19 21:11
今日重点评级关注:Ascendiant Capital:维持GRI Bio"买入"评级,目标价从35美元升至36美元;Ascendiant Capital:维持Atossa Therapeutics"买入"评级,目标价从7.75美元升至8美元
2025-12-09 10:32
JP Morgan analyst Mark Strouse upgrades Quanta Services (NYSE:PWR) from Neutral to Overweight and raises the price target from $457 to $515.
2025-12-08 20:42
Quanta Services (NYSE:PWR) has outperformed the market over the past 5 years by...
2025-11-20 23:45
HOUSTON, Nov. 18, 2025 /PRNewswire/ -- Quanta Services, Inc. (NYSE: PWR) announced today that its Board of Directors has declared a quarterly cash dividend to stockholders of $0.11 per share...
2025-11-18 19:55
今日重点评级关注:康托·菲茨杰拉德:维持Cabaletta Bio"超配"评级,目标价从15美元升至30美元;HC Wainwright & Co.:维持Invivyd"买入"评级,目标价从5美元升至10美元
2025-11-03 20:20